We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cambridge Epigenetix Licenses Fundamental DNA Methylation IP from Boston Children’s Hospital

Product News   Apr 28, 2017 | Original story from Cambridge Epigenetix

 
Cambridge Epigenetix Licenses Fundamental DNA Methylation IP from Boston Children’s Hospital

Anjana Rao. Credit: Cambridge Epigenetix

FURTHER INFORMATION
 
 
 

Related Product News

Thermo Fisher Scientific and NanoPin: Advancing Infectious Disease Detection Technology

Product News

Thermo Fisher Scientific and NanoPin have entered into a collaborative relationship to advance blood-based infectious disease detection technology.

READ MORE

Arbor Biosciences Offers Novel 2019 Coronavirus Panel for Free to Research Community

Product News

Arbor Biosciences has announced the release of a myBaits Expert hybridization-based panel for the 2019 Novel Coronavirus (2019-nCoV), free of charge to researchers.

READ MORE

Secure Sealing of SBS Format Tube Racks

Product News

Ziath has announced the launch of impressiOn - a semi-automatic device designed to take the strain out of applying friction sealing mats or septum sealing caps to SBS format tube racks.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE